Recent work in prostate cancer identified that PKD2 or PKD3 knockdown results in decreased expression and secretion of pro-inflammatory chemokines SCF, CCL5 and CCL11 in two prostate cancer cell lines, with the proteins contributing to the chemotactic migration of mast cells in vitro.81 This evidence concerns the gene PRKD3 and prostate carcinoma.